# Apnimed, Inc. — restructuring/exchange_offer [announced]
Source: SEC API (secapi.ai) · situation sit_1b41f851bdf0d3032591 · retrieved 2026-08-11T16:15:05.705Z

## Overview
Apnimed, Inc. is a pharmaceutical preparations company.

Apnimed, Inc., a pharmaceutical preparations company, consummated its initial public offering (IPO) of common stock on August 3, 2026. In connection with the IPO, the company filed its ninth amended and restated certificate of incorporation with the Delaware Secretary of State, effective immediately prior to the IPO closing. The restated certificate authorizes 500,000,000 shares of common stock and 10,000,000 shares of undesignated preferred stock, and eliminates all references to previously existing series of preferred stock.

## Key dates
- Announced 2026-08-03

## Timeline
- 2026-08-03 · 8-K (0001193125-26-330509): 8-K - Apnimed, Inc. — *Apnimed, Inc. is a pharmaceutical preparations company.* Apnimed, Inc., a pharmaceutical preparations company, consummated its initial public offering (IPO) of common stock on August 3, 2026. In connection with the IPO, the company filed its ninth amended and restated certificate of incorporation with the Delaware Secretary of State, effective immediately prior to the IPO closing. The restated certificate authorizes 500,000,000 shares of common stock and 10,000,000 shares of undesignated preferred stock, and eliminates all references to previously existing series of preferred stock.
  https://www.sec.gov/Archives/edgar/data/1745648/0001193125-26-330509.txt

## Citations
- 0001193125-26-330509 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526330509